Methenamine Hippurate

CHEMBL1201104 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
319.4 g/mol
LogP
Phase
4

A hippurate salt form of methenamine used to prevent recurrent urinary tract infections by releasing antibacterial formaldehyde in the bladder.

Molekularmasse

319,3600 g/mol

TPSA

79,40 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1

InChI

InChI=1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2

Molecular Formula

C15H21N5O3

HBD / HBA

2 / 7

Rotierbare Bindungen

3

Schwere Atome

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A hippurate salt form of methenamine used to prevent recurrent urinary tract infections by releasing antibacterial formaldehyde in the bladder.

Yes, Methenamine Hippurate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201104. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 21945. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.